121 related articles for article (PubMed ID: 26408729)
1. Stereotactic Radiotherapy in the Treatment of Lung Metastases from Bone and Soft-tissue Sarcomas.
Frakulli R; Salvi F; Balestrini D; Parisi A; Palombarini M; Cammelli S; Rocca M; Salone M; Longhi A; Ferrari S; Morganti AG; Frezza G
Anticancer Res; 2015 Oct; 35(10):5581-6. PubMed ID: 26408729
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival.
Dhakal S; Corbin KS; Milano MT; Philip A; Sahasrabudhe D; Jones C; Constine LS
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):940-5. PubMed ID: 21277105
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma.
Navarria P; Ascolese AM; Cozzi L; Tomatis S; D'Agostino GR; De Rose F; De Sanctis R; Marrari A; Santoro A; Fogliata A; Cariboni U; Alloisio M; Quagliuolo V; Scorsetti M
Eur J Cancer; 2015 Mar; 51(5):668-74. PubMed ID: 25686482
[TBL] [Abstract][Full Text] [Related]
4. Lung metastases treated with image-guided stereotactic body radiation therapy.
Baschnagel AM; Mangona VS; Robertson JM; Welsh RJ; Kestin LL; Grills IS
Clin Oncol (R Coll Radiol); 2013 Apr; 25(4):236-41. PubMed ID: 23352916
[TBL] [Abstract][Full Text] [Related]
5. Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases.
Kalinauskaite GG; Tinhofer II; Kufeld MM; Kluge AA; Grün AA; Budach VV; Senger CC; Stromberger CC
BMC Cancer; 2020 May; 20(1):404. PubMed ID: 32393261
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy in patients with stage I non-small-cell lung cancer aged 75 years and older: retrospective results from a multicenter consortium.
Samuels MA; Kandula S; Koru-Sengul T; Bogart JA; Salama JK; Aridgides PD; Gajra A; Lilenbaum RC
Clin Lung Cancer; 2013 Jul; 14(4):446-51. PubMed ID: 23660522
[TBL] [Abstract][Full Text] [Related]
7. Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry's experience.
Ricco A; Davis J; Rate W; Yang J; Perry D; Pablo J; D'Ambrosio D; Sharma S; Sundararaman S; Kolker J; Creach KM; Lanciano R
Radiat Oncol; 2017 Feb; 12(1):35. PubMed ID: 28143558
[TBL] [Abstract][Full Text] [Related]
8. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP
Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338
[TBL] [Abstract][Full Text] [Related]
9. Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicity.
Baumann BC; Bernstein KA; DeLaney TF; Simone CB; Kolker JD; Choy E; Levin WP; Weber KL; Muniappan A; Berman AT; Staddon A; Hartner L; Van Tine B; Hirbe A; Glatstein E; Hahn SM; Nagda SN; Chen YL
J Surg Oncol; 2020 Oct; 122(5):877-883. PubMed ID: 32588468
[TBL] [Abstract][Full Text] [Related]
10. Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: a retrospective analysis of 34 patients.
Scorsetti M; Alongi F; Filippi AR; Pentimalli S; Navarria P; Clerici E; Castiglioni S; Tozzi A; Reggiori G; Mancosu P; Ricardi U
Acta Oncol; 2012 May; 51(5):618-23. PubMed ID: 22263925
[TBL] [Abstract][Full Text] [Related]
11. Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases.
Thibault I; Campbell M; Tseng CL; Atenafu EG; Letourneau D; Yu E; Cho BC; Lee YK; Fehlings MG; Sahgal A
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):353-60. PubMed ID: 26383680
[TBL] [Abstract][Full Text] [Related]
12. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic Body Radiotherapy Versus Metastasectomy in Patients With Pulmonary Metastases From Soft Tissue Sarcoma.
Tetta C; Londero F; Micali LR; Parise G; Algargoush AT; Algargoosh M; Albisinni U; Maessen JG; Gelsomino S
Clin Oncol (R Coll Radiol); 2020 May; 32(5):303-315. PubMed ID: 32024603
[TBL] [Abstract][Full Text] [Related]
14. Translational and rotational intra- and inter-fractional errors in patient and target position during a short course of frameless stereotactic body radiotherapy.
Josipovic M; Persson GF; Logadottir A; Smulders B; Westmann G; Bangsgaard JP
Acta Oncol; 2012 May; 51(5):610-7. PubMed ID: 22263924
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: A potential alternative to resection.
Baumann BC; Nagda SN; Kolker JD; Levin WP; Weber KL; Berman AT; Staddon A; Hartner L; Hahn SM; Glatstein E; Simone CB
J Surg Oncol; 2016 Jul; 114(1):65-9. PubMed ID: 27111504
[TBL] [Abstract][Full Text] [Related]
16. Lung metastases in oligometastatic patients: outcome with stereotactic body radiation therapy (SBRT).
García-Cabezas S; Bueno C; Rivin E; Roldán JM; Palacios-Eito A
Clin Transl Oncol; 2015 Aug; 17(8):668-72. PubMed ID: 26022130
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiotherapy for colorectal lung oligometastases: preliminary single-institution results.
Carvajal C; Navarro-Martin A; Cacicedo J; Ramos R; Guedea F
J BUON; 2015; 20(1):158-65. PubMed ID: 25778311
[TBL] [Abstract][Full Text] [Related]
18. Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French sarcoma group.
Falk AT; Moureau-Zabotto L; Ouali M; Penel N; Italiano A; Bay JO; Olivier T; Sunyach MP; Boudou-Roquette P; Salas S; Le Maignan C; Ducassou A; Isambert N; Kalbacher E; Pan C; Saada E; Bertucci F; Thyss A; Thariat J;
Clin Oncol (R Coll Radiol); 2015 Jan; 27(1):48-55. PubMed ID: 25300878
[TBL] [Abstract][Full Text] [Related]
19. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
Rusthoven KE; Kavanagh BD; Burri SH; Chen C; Cardenes H; Chidel MA; Pugh TJ; Kane M; Gaspar LE; Schefter TE
J Clin Oncol; 2009 Apr; 27(10):1579-84. PubMed ID: 19255320
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiotherapy for oligometastatic lung tumors.
Norihisa Y; Nagata Y; Takayama K; Matsuo Y; Sakamoto T; Sakamoto M; Mizowaki T; Yano S; Hiraoka M
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):398-403. PubMed ID: 18374506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
